Hypofractionated stereotactic re-irradiation: treatment option in recurrent malignant glioma

Abstract

HFSRT with conservative total doses of no more than 30 Gy is safe and leads to similar OS times as more aggressive treatment schemes. In individual patients, HFSRT in combination with other salvage treatment modalities, was associated with long-term survival.